These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7002064)

  • 1. The antiperinuclear factor: II. A light microscopical and immunofluorescence study on the antigenic substrate.
    Smit JW; Sondag-Tschroots IR; Aaij C; Feltkamp TE; Feltkamp-Vroom TM
    Ann Rheum Dis; 1980 Aug; 39(4):381-6. PubMed ID: 7002064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of relationship between the Epstein-Barr virus and the antiperinuclear factor/'perinuclear antigen' system in rheumatoid arthritis.
    Buisson M; Berthelot JM; Le Goff P; Chastel C; Lamour A; Seigneurin JM; Youinou P
    J Autoimmun; 1994 Aug; 7(4):485-95. PubMed ID: 7980850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies.
    Sebbag M; Simon M; Vincent C; Masson-Bessière C; Girbal E; Durieux JJ; Serre G
    J Clin Invest; 1995 Jun; 95(6):2672-9. PubMed ID: 7539459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The perinuclear factor, a rheumatoid arthritis-specific autoantigen, is not present in keratohyalin granules of cultured buccal mucosa cells.
    Hoet RM; Voorsmit RA; Van Venrooij WJ
    Clin Exp Immunol; 1991 Apr; 84(1):59-65. PubMed ID: 1849807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin.
    Hoet RM; Boerbooms AM; Arends M; Ruiter DJ; van Venrooij WJ
    Ann Rheum Dis; 1991 Sep; 50(9):611-8. PubMed ID: 1718228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiperinuclear factor. 1. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis.
    Sondag-Tschroots IR; Aaij C; Smit JW; Feltkamp TE
    Ann Rheum Dis; 1979 Jun; 38(3):248-51. PubMed ID: 384931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiperinuclear factor and antikeratin antibody systems.
    Youinou P; Serre G
    Int Arch Allergy Immunol; 1995 Aug; 107(4):508-18. PubMed ID: 7542514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiperinuclear factor in an Italian series of patients with rheumatoid arthritis.
    Cassani F; Ferri S; Bianchi FB; Marsili R; Zauli D; Pisi E
    Ric Clin Lab; 1983; 13(3):347-52. PubMed ID: 6606208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the antiperinuclear factor (APF)].
    Nienhuis RL
    Ned Tijdschr Geneeskd; 1973 Oct; 117(42):1561-5. PubMed ID: 4545001
    [No Abstract]   [Full Text] [Related]  

  • 10. Histologic and electron microscopic characterization of the antiperinuclear factor antigen.
    Vivino FB; Maul GG
    Arthritis Rheum; 1990 Jul; 33(7):960-9. PubMed ID: 2196059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiperinuclear antibodies and corrisponding antigens].
    Youinou P; Berthelot JM; Péron A; Leroux AM; Le Goff P
    Rev Rhum Mal Osteoartic; 1992 Sep; 59(6 Pt 2):43S-51S. PubMed ID: 1485130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiperinuclear factor. I. Clinical and serologic associations.
    Youinou P; Le Goff P; Dumay A; Lelong A; Fauquert P; Jouquan J
    Clin Exp Rheumatol; 1990; 8(3):259-64. PubMed ID: 1696191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiperinuclear factor and keratin antibodies in rheumatoid arthritis.
    Johnson GD; Carvalho A; Holborow EJ; Goddard DH; Russell G
    Ann Rheum Dis; 1981 Jun; 40(3):263-6. PubMed ID: 6166255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiperinuclear factor in psoriatic arthropathy.
    Calzavara-Pinton PG; Franceschini F; Manera C; Zane C; Prati E; Cretti L; Braga S; Cattaneo R
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):910-3. PubMed ID: 10365921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiperinuclear factor of the IgA isotype in active rheumatoid arthritis.
    Berthelot JM; Bendaoud B; Maugars Y; Audrain M; Prost A; Youinou P
    Clin Exp Rheumatol; 1994; 12(6):615-9. PubMed ID: 7895395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process.
    Aho K; von Essen R; Kurki P; Palosuo T; Heliövaara M
    J Rheumatol; 1993 Aug; 20(8):1278-81. PubMed ID: 7693940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiperinuclear factor. II. Variability of the perinuclear antigen.
    Youinou P; Seigneurin JM; Le Goff P; Dumay A; Vicariot M; Lelong A
    Clin Exp Rheumatol; 1990; 8(3):265-9. PubMed ID: 2165883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiperinuclear factors in psoriasis. Correlation with other serological abnormalities in 90 patients].
    Youinou P; Massé R; Peu-Duvallon P; Le Roux P; Grulier A; Miossec P; Dorval JC; Lizan G; Férec C; Le Goff P
    Ann Dermatol Venereol; 1982; 109(4):359-64. PubMed ID: 6751193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative characteristics of specific autoantibodies in rheumatoid arthritis].
    Lapin SV; Maslianskiĭ AL; Mazurov VI; Totolian AA
    Ter Arkh; 2005; 77(12):53-9. PubMed ID: 16514821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiperinuclear factor as a prognostic marker in rheumatoid arthritis.
    Muñoz-Fernández S; Alvarez-Doforno R; González-Tarrio JM; Balsa A; Richi P; Fontán G; Gijón-Baños J; Martin-Mola E
    J Rheumatol; 1999 Dec; 26(12):2572-7. PubMed ID: 10606364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.